MYRIAD GENETICS INC - FORM 10-Q - EX-32.1 - CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - February 1, 2011

Attached files

file filename
10-Q - FORM 10-Q - MYRIAD GENETICS INCd10q.htm
EX-10.3 - FORM OF STOCK OPTION AGREEMENT UNDER THE 2010 EQUITY INCENTIVE PLAN - MYRIAD GENETICS INCdex103.htm
EX-10.2 - EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED - MYRIAD GENETICS INCdex102.htm
EXCEL - IDEA: XBRL DOCUMENT - MYRIAD GENETICS INCFinancial_Report.xls
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) - MYRIAD GENETICS INCdex311.htm
EX-10.4 - FORM OF DIRECTOR STOCK OPTION AGREEMENT UNDER THE 2010 EQUITY INCENTIVE PLAN - MYRIAD GENETICS INCdex104.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) - MYRIAD GENETICS INCdex312.htm

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 1, 2011     Date: February 1, 2011
By:   /s/ Peter D. Meldrum     By:   /s/ James S. Evans
Peter D. Meldrum     James S. Evans
President and Chief Executive Officer     Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Stock widget

Investing forum

MYRIAD GENETICS INC Reports